Phase Ii Study Of Weekly Administration Of Docetaxel (D) In Combination With The Epidermal Growth Factor Receptor (Egfr) Inhibitor Erlotinib (E) In Metastatic Breast Cancer (Mbc)
CANCER RESEARCH(2009)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要